ResearcherTechnion – Israel Institute of TechnologyNo recent work listed
Jesse Lachter
Matched on ORCID iD 0000-0001-8567-2903; OpenAlex author ID A5044538643. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 5
- Multisite Is Superior to Single-Site Intratumoral Chemotherapy to Retard the Outcomes of Pancreatic Ductal Adenocarcinoma in a Murine Model. Co-author DOI 10.3390/cancers15245801↗
- Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Co-author DOI 10.1053/j.gastro.2021.10.014↗
- Surveillance for pancreatic cancer in high-risk individuals. Co-author DOI 10.1002/bjs5.50180↗
- Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience. Co-author DOI 10.5041/rmmj.10353↗
- Exposure during pancreatic surgery. Do we have to examine the falciform and round ligaments for pancreatic cancer metastasis? Co-author DOI 10.6092/1590-8577/3342↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jacob Benarie · 1 shared paper, 2023 · strength 0.24
- Janette Lazarovits · 1 shared paper, 2023 · strength 0.24
- Elizabeth Half · 2 shared papers, 2018–2022 · strength 0.20
- Paper Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. DOI 10.1053/j.gastro.2021.10.014↗
- Paper Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience. DOI 10.5041/rmmj.10353↗
- Ingrid C. A. W. Konings · 2 shared papers, 2019–2022 · strength 0.18
- Marcia Irene Canto · 2 shared papers, 2019–2022 · strength 0.18
- Jeanin Elise van Hooft · 2 shared papers, 2019–2022 · strength 0.18
- Marco J. Bruno · 2 shared papers, 2019–2022 · strength 0.18
- Randall E. Brand · 2 shared papers, 2019–2022 · strength 0.18
- Michael Goggins · 2 shared papers, 2019–2022 · strength 0.18
- Sapna Syngal · 2 shared papers, 2019–2022 · strength 0.18
- Aimee Lee Lucas · 2 shared papers, 2019–2022 · strength 0.18
- Salvatore Paiella · 2 shared papers, 2019–2022 · strength 0.18
- Elena M. Stoffel · 2 shared papers, 2019–2022 · strength 0.18
- Fay Kastrinos · 2 shared papers, 2019–2022 · strength 0.18
- Brechtje D.M. Koopmann · 1 shared paper, 2022 · strength 0.10
- Iris J. M. Levink · 1 shared paper, 2022 · strength 0.10
- Kasper A. Overbeek · 1 shared paper, 2022 · strength 0.10
- Detlef Klaus Bartsch · 1 shared paper, 2022 · strength 0.10
- Alfredo Carrato · 1 shared paper, 2022 · strength 0.10
- Nirav C Thosani · 1 shared paper, 2022 · strength 0.10
- Djuna L. Cahen · 1 shared paper, 2022 · strength 0.10
- Alina Stoita · 1 shared paper, 2022 · strength 0.10
- Thomas Mathias Gress · 1 shared paper, 2022 · strength 0.10
- Julie Earl · 1 shared paper, 2022 · strength 0.10
- Giuseppe Malleo · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.